Literature DB >> 9688340

Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation.

M S Exton1, S von Hörsten, M Schult, J Vöge, T Strubel, S Donath, C Steinmüller, H Seeliger, E Nagel, J Westermann, M Schedlowski.   

Abstract

Bi-directional interactions between the central nervous system (CNS) and immune system are demonstrated by the modification of immune function using behavioral conditioning. However, the mechanisms by which the CNS achieves conditioned immunomodulation are still in question. Here, we report that the immunosuppressive effects of cyclosporine A (CsA) can be behaviorally conditioned in rats using saccharin as a gustatory conditioned stimulus. The conditioned effects were compared to control groups that received CsA paired with water (sham-conditioned), CsA injection on test days (CsA-treated), and unhandled rats (untreated). In conditioned animals, the mitogen-induced lymphocyte proliferation in the spleen is significantly suppressed, and the survival time of heterotopic heart allografts prolonged. These effects are paralleled by conditioned inhibition of IL-2 and IFN-gamma synthesis by splenocytes. Furthermore, the CNS-induced immunosuppression is mediated neuronally and not via the blood, since the conditioned reduction of proliferation and cytokine production is completely abrogated after surgical denervation of the spleen. Thus, during conditioning, the CNS learns to reinstate at demand a CsA-like immunosuppression via splenic innervation. This might be used as a supportive therapy for controlling immune functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688340     DOI: 10.1016/s0165-5728(98)00122-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Behavioural conditioning as the mediator of placebo responses in the immune system.

Authors:  Sabine Vits; Elvir Cesko; Paul Enck; Uwe Hillen; Dirk Schadendorf; Manfred Schedlowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

2.  Conditioned pharmacotherapeutic effects: a preliminary study.

Authors:  Robert Ader; Mary Gail Mercurio; James Walton; Deborra James; Michael Davis; Valerie Ojha; Alexa Boer Kimball; David Fiorentino
Journal:  Psychosom Med       Date:  2009-12-22       Impact factor: 4.312

3.  Conditioned effects of ethanol on the immune system.

Authors:  Anny Gano; Ricardo Marcos Pautassi; Tamara L Doremus-Fitzwater; Terrence Deak
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

4.  Dopamine affects cellular immune functions during polymicrobial sepsis.

Authors:  Reiner Oberbeck; Daniel Schmitz; Klaus Wilsenack; Mark Schüler; Baher Husain; Manfred Schedlowski; Michael S Exton
Journal:  Intensive Care Med       Date:  2006-04-01       Impact factor: 17.440

5.  Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning.

Authors:  Richard E Jones; Nicole Moes; Heather Zwickey; Christopher L Cunningham; William L Gregory; Barry Oken
Journal:  Brain Behav Immun       Date:  2007-12-26       Impact factor: 7.217

6.  Dehydroepiandrosterone: a modulator of cellular immunity and heat shock protein 70 production during polymicrobial sepsis.

Authors:  Reiner Oberbeck; Hanno Deckert; Jörg Bangen; Phillip Kobbe; Daniel Schmitz
Journal:  Intensive Care Med       Date:  2007-09-26       Impact factor: 17.440

Review 7.  Placebo and the new physiology of the doctor-patient relationship.

Authors:  Fabrizio Benedetti
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

8.  Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.

Authors:  Timothy B Saurer; Stephanie G Ijames; Kelly A Carrigan; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2007-08-03       Impact factor: 7.217

Review 9.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

10.  Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus.

Authors:  Christina L Lebonville; Meghan E Jones; Lee W Hutson; Letty B Cooper; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2016-04-09       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.